Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia

Published:2014-12-19 Issue:3 Volume:100 Page:392-399
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Brissot E.,Labopin M.,Beckers M. M.,Socie G.,Rambaldi A.,Volin L.,Finke J.,Lenhoff S.,Kroger N.,Ossenkoppele G. J.,Craddock C. F.,Yakoub-Agha I.,Gurman G.,Russell N. H.,Aljurf M.,Potter M. N.,Nagler A.,Ottmann O.,Cornelissen J. J.,Esteve J.,Mohty M.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of blinatumomab as bridge-to-transplant for B-cell acute lymphoblastic leukemia in first complete remission with no detectable minimal residual disease;Blood Cancer Journal;2024-08-23

2. Impact of the Type of Tyrosine Kinase Inhibitor (imatinib or dasatinib) Used Before allo-HCT on Outcome of Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia. A Study on Behalf of the Acute Leukemia Working Party of the EBMT;Transplantation and Cellular Therapy;2024-07

3. Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions;Leukemia;2024-06-20

4. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13

5. Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission;Cancers;2024-05-31